Trial description:
Adjuvant therapy with pembrolizumab versus placebo in resected stage II melanoma: a randomized, double-blind phase III study
Contact name:
Dr Pippa Corrie
Trial start date:
Thursday, October 25, 2018
Trial end date:
Friday, July 31, 2020
Trial tumour type:
Skin & melanoma
Show on Radiotherapy:
No
